期刊文献+

低分子肝素对大鼠脑局灶性缺血再灌注后Bcl-2,Bax表达的影响及保护作用 被引量:1

Effect of low molecular weight heparin on the expressions of Bcl-2, Bax and its neuroprotective effects after focal cerebral ischemia/reperfusion in rats
暂未订购
导出
摘要 目的:观察低分子肝素对大鼠脑缺血再灌注后不同时间点Bcl-2,Bax表达的影响及保护作用.方法:①选用雄性SD大鼠54只,体质量280~330g.应用随机数字表法将大鼠分为3组:假手术组、缺血再灌注组和低分子肝素组,每组18只.②应用免疫组化方法测定海马CA1区神经元细胞凋亡基因Bcl-2,Bax表达情况.③采用两样本均数的t检验对两组间数据进行分析.结果:大鼠54只均进入结果分析,缺血再灌注组大鼠脑缺血再灌注6,12,24h时Bcl-2蛋白在神经元内表达的阳性细胞数较低分子肝素组同一时间点明显减少,两组比较具有显著的统计学意义(P<0.05).缺血再灌注组大鼠脑缺血再灌注6,12,24h时Bax蛋白表达的阳性细胞数较低分子肝素组同一时间点明显增加,两组比较具有显著的统计学意义(P<0.05).结论:脑缺血再灌注损伤随再灌注时间延长而加重,低分子肝素可能通过减少Bax蛋白的表达,上调Bcl-2蛋白表达,从而减轻神经元的损伤及凋亡,起到脑保护作用. AIM: To study the effect of low molecular weight heparin on the expressions of Bcl-2, Bax and its neuroprotective effects after focal cerebral ischemia reperfusion in rats. METHODS : Totally 54 male SD rats, with the body mass of 280 - 330 g were selected and randomly assigned into 3 groups : sham operation group, ischemia/reperfusion group, low molecular weight heparin group with 18 in each group. The expressions of Bcl-2, Bax were checked by immunohistochemistry in hippocam- pal CA1 subregion. All data in the groups were analyzed with t test. RESULTS: Totally 54 rats were involved in the result analysis. Bcl-2 positive cell number in the ischemia/reperfusion group decreased significantly as compared with that in the low moleucular heparin group at 6, 12, 24 h of reperfusion (P 〈0.05). Bax expression was significantly decreased in the low molecular weight heparin group, as compared with that in the ischemia/reperfusion group at 6, 12, 24 h of reperfusion ( P 〈 0. 05 ). CONCLU- SION: Low molecular weight heparin can increase the expression of Bcl-2, decrease the expression of Bax, alleviate the pathological change induced by cerebral ischemia/reperfusion. Low molecular weight heparin exerts the neuroprotective effect against the brain injury induced by cerebral ischemia/reperfusion by restraining cell apoptosis.
出处 《第四军医大学学报》 北大核心 2007年第9期819-821,共3页 Journal of the Fourth Military Medical University
关键词 大鼠 脑缺血再灌注 低分子肝素 Bcl-2 BAX rats cerebral ischemia reperfusion low molecularweight heparin Bcl-2 Bax
  • 相关文献

参考文献7

  • 1Tsuchidate R,He QP,Smith ML,et al.Regional cerebral blood flow during and after 2 hours of middle cerebral artery occlusion in the rat[J].Cereb Blood Flow Metab,1997,17(10):1066-1073.
  • 2Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
  • 3Schabitz WR,Sommer C,Zoder W,et al.Intravenous brain-derived neurotrophic actor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia[J].Stroke,2000,31(9):2212-2217.
  • 4郭云良,高英茂.脑缺血再灌注后神经元和内皮细胞凋亡与Bcl-2和Bax表达的时相关系[J].解剖学报,2002,33(2):151-156. 被引量:28
  • 5上海市急性脑血管病规范化治疗协作组.低分子肝素治疗急性脑梗死的前瞻性多中心随机对照临床研究[J].中国临床神经科学,2003,11(2):175-177. 被引量:15
  • 6Quartermain D,Li YS,Jonas S.The low molecular weight heparin enoxaparin reduces infarct size in a rat model of temporary focal ischemia[J].Cerebrovasc Dis,2003,16(4):346-355.
  • 7Stutzmann JM,Mary V,Wahl F,et al.Neuroprotective profile of enoxaparin,a low molecular weight heparin,in in vivo models of cerebral ischemia or traumatic brain injury in rats:A review[J].CNS Drug Rev,2002,8(1):1-30.

二级参考文献9

  • 1Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke[J]. N Engl J Med 1995,333:1588-1593.
  • 2Hart RG, Easton JD, Do we really head a beher way to give heparin in acute cerebral ischemia? [ J ]. Stroke, 2000, 33 : 659-660.
  • 3The publication committee for the trial of ORG 10172 in acute stroke treatment (TOAST) investigators. Low molecular weight heparinoid, OGR 10172(danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial[J] .JAMS, 1998,279:1265-1272.
  • 4International Stroke Trial Collaborative Group. The international stroke trial(1ST) : a randomised trial og aspirin, subcutaneous heparin, both, or neither among 19435 patients gith acute ischaemic stroke[J]. Lancet, 1997,349:1569-1581.
  • 5Philip M, WB Robert 1, Fiona JB. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomizd controlled trials[J]. Stroke,2000,31 : 1770-1778.
  • 6Diener HC, Ringelstein EB, Kammer RV, et al.Treatment of acute stroke with the low-molecular-weight heparin certoparin. Results of the TOPAS trial[ J]. Stroke, 2001,32: 22-29.
  • 7Berge E. Ahdelnoor M, Nakstad PH, et al. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation:a doubel-blind randomized study. HAEST Study Group. Heparin in acute embolic stroke trial . Lancet 2000, 355(9211 ) : 1205-1210.
  • 8Lensing WA, Prins MH, Davidson BL, et al. Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis [ J ]. Arch Interm Med, 1995,155:601-607.
  • 9赵士福,蔡文琴.脑缺血过程中B细胞淋巴瘤-2基因家族基因的表达及与细胞死亡的关系[J].解剖学报,1998,29(2):119-123. 被引量:26

共引文献41

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部